Ancora Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $56.4K | Buy |
646
+624
| +2,836% | +$54.5K | ﹤0.01% | 986 |
|
2025
Q1 | $1.5K | Sell |
22
-8
| -27% | -$546 | ﹤0.01% | 1529 |
|
2024
Q4 | $2.31K | Sell |
30
-80
| -73% | -$6.15K | ﹤0.01% | 1531 |
|
2024
Q3 | $7.35K | Buy |
110
+2
| +2% | +$134 | ﹤0.01% | 1361 |
|
2024
Q2 | $12.2K | Hold |
108
| – | – | ﹤0.01% | 1230 |
|
2024
Q1 | $14.9K | Hold |
108
| – | – | ﹤0.01% | 1213 |
|
2023
Q4 | $13.4K | Hold |
108
| – | – | ﹤0.01% | 1203 |
|
2023
Q3 | $10K | Hold |
108
| – | – | ﹤0.01% | 1245 |
|
2023
Q2 | $13.8K | Buy |
108
+8
| +8% | +$1.03K | ﹤0.01% | 1179 |
|
2023
Q1 | $11.6K | Sell |
100
-6
| -6% | -$697 | ﹤0.01% | 1210 |
|
2022
Q4 | $12K | Buy |
106
+6
| +6% | +$679 | ﹤0.01% | 1256 |
|
2022
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 1489 |
|
2022
Q2 | $7K | Hold |
100
| – | – | ﹤0.01% | 1635 |
|
2022
Q1 | $13K | Hold |
100
| – | – | ﹤0.01% | 1622 |
|
2021
Q4 | $13K | Buy |
+100
| New | +$13K | ﹤0.01% | 1697 |
|